Phase 4, Post-Marketing Safety Surveillance of the MF59-Adjuvanted Influenza Vaccines FLUAD(®) and VANTAFLU(®) in South Korean Subjects Aged ≥65 Years

nork Yoo, Byung Wook, Kim, Chang Oh, Izu, Allen, Arora, Ashwani Kumar, Heijnen, Esther
Argitaratua izan da Infect Chemother (2018)

Repeated ovarian stimulation with corifollitropin alfa in patients in a GnRH antagonist protocol: no concern for immunogenicity

nork Norman, Robert J., Zegers-Hochschild, Fernando, Salle, Bruno S., Elbers, Jolanda, Heijnen, Esther, Marintcheva-Petrova, Maya, Mannaerts, Bernadette
Argitaratua 2011

987. Repeated Exposure to an Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV): A Randomized, Observer Blind, Multicenter Study

nork Daly, Wendy, Ramsey, Keith, Forsten, Aino, Heijnen, Esther, Leav, Brett, Oberye, Janine, Zhang, Bin, Pacciarini, Filippo, Vesikari, Timo
Argitaratua izan da Open Forum Infect Dis (2018)

Immunogenicity and Safety of an MF59-adjuvanted Quadrivalent Seasonal Influenza Vaccine in Young Children at High Risk of Influenza-associated Complications: A Phase III, Randomize...

nork Esposito, Susanna, Fling, John, Chokephaibulkit, Kulkanya, de Bruijn, Marianne, Oberye, Janine, Zhang, Bin, Vossen, Jeanique, Heijnen, Esther, Smolenov, Igor
Argitaratua izan da Pediatr Infect Dis J (2020)

Immunogenicity and safety of investigational vaccine formulations against meningococcal serogroups A, B, C, W, and Y in healthy adolescents

nork Saez-Llorens, Xavier, Aguilera Vaca, Diana Catalina, Abarca, Katia, Maho, Emmanuelle, Graña, Maria Gabriela, Heijnen, Esther, Smolenov, Igor, Dull, Peter M
Argitaratua izan da Hum Vaccin Immunother (2015)

MF59-adjuvanted influenza vaccine (FLUAD®) elicits higher immune responses than a non-adjuvanted influenza vaccine (Fluzone®): A randomized, multicenter, Phase III pediatric trial...

nork Cruz-Valdez, Aurelio, Valdez-Zapata, Gabriel, Patel, Sanjay S., Castelli, Flavia V., Garcia, Marcia G., Jansen, Wim T., Arora, Ashwani Kumar, Heijnen, Esther
Argitaratua izan da Hum Vaccin Immunother (2018)

902. A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of a Single Immunization of Ad26.RSV.preF against RSV Infection in a Viral Challenge Model in Hea...

nork DeVincenzo, John, Gymnopoulou, Efi, De Paepe, Els, Murray, Bryan, Rosemary Bastian, Arangassery, Haazen, Wouter, Noulin, Nicolas, Comeaux, Christy, Heijnen, Esther, Eze, Kinglsey, Gilbert, Anthony, Lambkin-Williams, Rob, Schuitemaker, Hanneke, Callendret, Benoit, Sadoff, Jerald
Argitaratua izan da Open Forum Infect Dis (2019)

Vaccines based on replication incompetent Ad26 viral vectors: Standardized template with key considerations for a risk/benefit assessment()

nork Custers, Jerome, Kim, Denny, Leyssen, Maarten, Gurwith, Marc, Tomaka, Frank, Robertson, James, Heijnen, Esther, Condit, Richard, Shukarev, Georgi, Heerwegh, Dirk, van Heesbeen, Roy, Schuitemaker, Hanneke, Douoguih, Macaya, Evans, Eric, Smith, Emily R., Chen, Robert T.
Argitaratua izan da Vaccine (2021)